Efavirenz binding to HIV-1 reverse transcriptase monomers and dimers.
Efavirenz binding to HIV-1 reverse transcriptase monomers and dimers.
复制标题
DOI:
10.1021/bi901579y
复制
发表时间:
2010-01-26
期刊:
影响因子:
2.9
通讯作者:
Barkley, Mary D.
中科院分区:
文献类型:
--
作者:
Braz, Valerie A.;Holladay, Leslie A.;Barkley, Mary D.
Efavirenz (EFV) is a nonnucleoside reverse transcriptase inhibitor (NNRTI) of HIV-1 reverse transcriptase (RT) used for the treatment of AIDS. RT is a heterodimer composed of p66 and p51 subunits; p51 is produced from p66 by C-terminal truncation by HIV protease. The monomers can form p66/p66 and p51/p51 homodimers as well as p66/p51 heterodimer. Dimerization and efavirenz binding are coupled processes. In the crystal structure of the p66/p51—EFV complex, the drug is bound to the p66 subunit. The binding of efavirenz to wild-type and dimerization-defective RT proteins was studied by equilibrium dialysis, tryptophan fluorescence and native gel electrophoresis. A 1:1 binding stoichiometry was determined for both monomers and homodimers. Equilibrium dissociation constants are ~2.5 μM for both p66— and p51—EFV complexes, 250 nM for p66/p66—EFV complex, and 7 nM for p51/p51—EFV complex. An equilibrium dissociation constant of 92 nM for p66/p51—EFV complex was calculated from the thermodynamic linkage between dimerization and inhibitor binding. Binding and unbinding kinetics monitored by fluorescence were slow. Progress curve analyses revealed a one-step, direct binding mechanism with association rate constants k1 ~13.5 M–1 s–1 for monomers and heterodimer and dissociation rate constants k–1 ~1 × 10–4 s–1 for monomers. A conformational selection mechanism is proposed to account for the slow association rate. These results show that efavirenz is a slow, tight-binding inhibitor capable of binding all forms of RT and suggest that the NNRTI binding site in monomers and dimers is similar.
登录
查看更多内容
影响因子:
2.9
作者:
Braz VA;Howard KJ
通讯作者:
Howard KJ
影响因子:
6.7
作者:
Figueiredo A;Moore KL;Mak J;Sluis-Cremer N;de Bethune MP;Tachedjian G
通讯作者:
Tachedjian G
影响因子:
2.9
作者:
Ghosh, M;Jacques, PS;leGrice, SFJ
通讯作者:
leGrice, SFJ
影响因子:
2.9
作者:
Ignatov, ME;Berdis, AJ;Barkley, MD
通讯作者:
Barkley, MD
影响因子:
3.5
作者:
RESTLE, T;MULLER, B;GOODY, RS
通讯作者:
GOODY, RS